Tissue kallikrein in transplant kidney.
Literature survey, thus far, has shown a decrease in the excretion of urinary tissue kallikrein (TK) in transplant patients with a further reduction of the enzyme during episodes of acute rejection. The study aims were to compare, at cellular and subcellular levels, the localisation of tissue kallikrein in biopsies of the transplant kidney to autopsy derived normal renal tissue. Renal biopsies from eighteen transplant patients with deteriorating renal function were obtained. Immunolabelling for tissue kallikrein, using a polyclonal goat anti-TK, antibody raised against recombinant TK, was performed following routine enzymatic, immunofluorescence and electron microscopic techniques. In normal kidney tissue, TK was immunolocalised in the distal connecting tubules and collecting ducts. By comparison the renal transplant tissue showed a reduction in the intensity of label, but maintained the sites of localisation. In the sections examined by electron microscopy, although TK was confined mainly at the luminal side of the cell, some label was noted along the basolateral membranes. In the transplant kidneys, there was a reduction in the overall number of gold particles counted, which correlated with the decreased intensity observed on immunocytochemistry. In addition, there was a shift to a basolateral orientation of the immunolabel. Acute rejection is characterised by oedema, tubulitis and vasculitis. Destruction of the tubule cells and leakage of TK into the interstitial tissue space and the resultant effect of the formed kinins on renal capillary vasculature could explain the observed renal parenchymal oedema and transplant rejection.
Ramsaroop
R
R
Department of Clinical and Experimental Pharmacology, University of Natal Medical School, Durban, South Africa.
Naicker
S
S
Naicker
T
T
Naidoo
S
S
Bhoola
K D
KD
D000328:Adult; D000818:Animals; D000918:Antibody Specificity; D001344:Autopsy; D001706:Biopsy; D001920:Bradykinin / Q000378:metabolism; D005260:Female; D006041:Goats; D006084:Graft Rejection / Q000209:etiology / Q000378:metabolism* / Q000503:physiopathology; D006801:Humans; D007124:Immunoenzyme Techniques; D007150:Immunohistochemistry; D007610:Kallikreins / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D007668:Kidney / Q000098:blood supply / Q000378:metabolism* / Q000473:pathology; D016030:Kidney Transplantation / Q000009:adverse effects / Q000502:physiology*; D008297:Male; D018613:Microscopy, Confocal; D016253:Microscopy, Immunoelectron; D008872:Microwaves; D011994:Recombinant Proteins; D020840:Tissue Kallikreins
D011994:Recombinant Proteins; D007610:Kallikreins; D020840:Tissue Kallikreins; D001920:Bradykinin